Please login to the form below

Not currently logged in
Email:
Password:

Michael J Fox Foundation

This page shows the latest Michael J Fox Foundation news and features for those working in and with pharma, biotech and healthcare.

Pfizer joins up with IBM for internet-of-things collaboration

Pfizer joins up with IBM for internet-of-things collaboration

Wearables have piqued the industry's interest in Parkinson's, with UCB beginning trials of a wearable sensor in December, the Michael J Fox Foundation backing a different trial earlier this

Latest news

  • Michael J Fox Foundation backs wearable device trial Michael J Fox Foundation backs wearable device trial

    Michael J Fox Foundation backs wearable device trial. Partners with chip manufacturer Intel and Cynapsus Therapeutics on Parkinson's study. ... Trials of a new therapy for Parkinson's disease developed by Cynapsus Therapeutics will use a smartwatch-like

  • UCB trials wearable sensor for Parkinson's UCB trials wearable sensor for Parkinson's

    Earlier this year the Michael J Fox Foundation, which funded the first web-based system to remotely access data from 'miniature sensors attached to the body' in 2008, tied up with ... The Michael J Fox Foundation also collaborated with biotech Sage

  • Another $2m donated to further neurodegenerative commitment Another $2m donated to further neurodegenerative commitment

    Fox Foundation for Parkinson's Research in the US, the Weston Brain Institute in Canada and Alzheimer's Research UK, which joins as the programme makes a second round of research ... Fox Foundation, added: “ A collaboration such as BAND promotes

  • Charity coalition pledges millions for brain disease research Charity coalition pledges millions for brain disease research

    Neuro– MAP's partners are Alzheimer's Association US, Alzheimer Research UK, Alzheimer's Society UK, ALS Association, Michael J Fox Foundation, MND Association, MRC Technology, Northern Health Science Alliance and

  • Roche signs Parkinson's deal with Prothena Roche signs Parkinson's deal with Prothena

    deal with Amicus Therapeutics, and Lundbeck, which has received funding from Parkinson's charity the Michael J Fox Foundation.

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics